MA32618B1 - Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives - Google Patents

Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives

Info

Publication number
MA32618B1
MA32618B1 MA33679A MA33679A MA32618B1 MA 32618 B1 MA32618 B1 MA 32618B1 MA 33679 A MA33679 A MA 33679A MA 33679 A MA33679 A MA 33679A MA 32618 B1 MA32618 B1 MA 32618B1
Authority
MA
Morocco
Prior art keywords
octahydro
indole
methyl ester
acid methyl
oxo
Prior art date
Application number
MA33679A
Other languages
Arabic (ar)
English (en)
Inventor
Ernst Kuesters
Murat Acemoglu
Philipp Lustenberger
Gottfried Sedelmeier
Beat Schmidt
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41278189&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32618(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32618B1 publication Critical patent/MA32618B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

La présente invention porte sur un procédé de production d'ester méthylique d'acide (3ar, 4s,7ar)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylique (i), d'énantiomères d'ester (2-chloroéthyl) (3-oxocyclohexyl)-alkylique de l'acide carbamique (ii)et d'énantiomères de 1-carbalcoxy-4-cétoperhydroindole (iii).
MA33679A 2008-08-12 2011-03-07 Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives MA32618B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8815608P 2008-08-12 2008-08-12
PCT/EP2009/060351 WO2010018154A1 (fr) 2008-08-12 2009-08-10 Procédés de préparation d'ester méthylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses dérivés

Publications (1)

Publication Number Publication Date
MA32618B1 true MA32618B1 (fr) 2011-09-01

Family

ID=41278189

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33679A MA32618B1 (fr) 2008-08-12 2011-03-07 Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives

Country Status (22)

Country Link
US (1) US8084487B2 (fr)
EP (1) EP2315748B1 (fr)
JP (1) JP5468608B2 (fr)
KR (1) KR101673634B1 (fr)
CN (1) CN102119151A (fr)
AU (1) AU2009281218B2 (fr)
BR (1) BRPI0917492A8 (fr)
CA (1) CA2732095C (fr)
CL (1) CL2011000296A1 (fr)
CO (1) CO6341608A2 (fr)
EC (1) ECSP11010883A (fr)
ES (1) ES2547269T3 (fr)
HK (1) HK1155733A1 (fr)
IL (1) IL210835A (fr)
MA (1) MA32618B1 (fr)
MX (1) MX2011001664A (fr)
MY (1) MY151183A (fr)
NZ (1) NZ590753A (fr)
PE (1) PE20110415A1 (fr)
RU (1) RU2513856C2 (fr)
WO (1) WO2010018154A1 (fr)
ZA (1) ZA201100558B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012084873A1 (fr) 2010-12-20 2012-06-28 Novartis Ag Esters d'acides 4-(hétéro)aryl-éthynyl-octahydro-indole-1-carboxyliques
EP2668159A1 (fr) 2011-01-24 2013-12-04 Novartis AG Dérivés de 4-tolyl-éthynyl-octahydro-indole-1-ester
EP2650284A1 (fr) 2012-04-10 2013-10-16 Merz Pharma GmbH & Co. KGaA Dérivés hétérocycliques comme modulateurs de récepteurs du glutamate métabotropique
US11878001B2 (en) 2017-07-31 2024-01-23 Novartis Ag Use of mavoglurant in the reduction of ***e use or in preventing relapse into ***e use
CN110891564A (zh) 2017-07-31 2020-03-17 诺华股份有限公司 玛沃谷兰在减少酒精使用或在预防复用酒精中的用途
EA202191812A1 (ru) 2019-01-29 2021-10-25 Новартис Аг ПРИМЕНЕНИЕ АНТАГОНИСТА mGluR5 ДЛЯ ЛЕЧЕНИЯ ТОЛЕРАНТНОСТИ К ОПИОИДНЫМ АНАЛЬГЕТИКАМ
KR20230041006A (ko) 2020-07-17 2023-03-23 노파르티스 아게 오피오이드 사용 감소 치료에 사용하기 위한 mglur5 길항제 마보글루란트
CN116710084A (zh) 2020-12-11 2023-09-05 诺华股份有限公司 mGluR5拮抗剂用于治疗***成瘾的用途
CN116981456A (zh) 2020-12-14 2023-10-31 诺华股份有限公司 mGluR5拮抗剂用于治疗赌博障碍的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds
CA2663113A1 (fr) * 2006-09-11 2008-03-20 Novartis Ag Utilisation de derives de l'acide nicotinique comme modulateurs des recepteurs metabotropes du glutamate
KR101572280B1 (ko) * 2007-10-12 2015-11-26 노파르티스 아게 파킨슨병의 치료를 위한 대사성 글루타메이트 수용체 조절제
RU2496494C2 (ru) * 2008-06-30 2013-10-27 Новартис Аг КОМБИНАЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ mGluR, ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА

Also Published As

Publication number Publication date
ECSP11010883A (es) 2011-04-29
AU2009281218B2 (en) 2013-05-16
HK1155733A1 (en) 2012-05-25
IL210835A0 (en) 2011-04-28
CA2732095A1 (fr) 2010-02-18
IL210835A (en) 2016-05-31
NZ590753A (en) 2012-06-29
JP5468608B2 (ja) 2014-04-09
KR101673634B1 (ko) 2016-11-07
JP2011530566A (ja) 2011-12-22
ES2547269T3 (es) 2015-10-05
EP2315748B1 (fr) 2015-06-24
US20110144352A1 (en) 2011-06-16
ZA201100558B (en) 2011-10-26
MY151183A (en) 2014-04-30
RU2513856C2 (ru) 2014-04-20
CL2011000296A1 (es) 2011-11-04
PE20110415A1 (es) 2011-07-04
CN102119151A (zh) 2011-07-06
RU2011108663A (ru) 2012-09-20
AU2009281218A1 (en) 2010-02-18
MX2011001664A (es) 2011-03-25
BRPI0917492A2 (pt) 2015-08-04
BRPI0917492A8 (pt) 2016-07-05
CA2732095C (fr) 2017-04-25
EP2315748A1 (fr) 2011-05-04
WO2010018154A1 (fr) 2010-02-18
KR20110042222A (ko) 2011-04-25
US8084487B2 (en) 2011-12-27
CO6341608A2 (es) 2011-11-21

Similar Documents

Publication Publication Date Title
MA32618B1 (fr) Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives
CY1118992T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξαμιδο-πυριδινο βενζοϊκων οξεων
ATE502001T1 (de) Herstellung von essigsäure
FR2897059B1 (fr) Procede de preparation d'acide acrylique
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
DK1987152T3 (da) Fremgangsmåde til fremstilling af optisk aktive chirale aminer
ITMI20081164A1 (it) Processo per la produzione di esteri dell'acido levulinico da biomasse
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
FR2938536B1 (fr) Procede de fabrication d'un methacrylate de methyle derive de la biomasse
FR2884817B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
MA32297B1 (fr) Procede de preparation de derives d'acide 1-(2-halobiphenyl-4-yl)-cyclopropane carboxylique
DE602004008183D1 (de) Verfahren zur Herstellung von L-Cystein unter Verwendung eines zur Gattung Escherichia gehörenden Bakteriums
AR062504A1 (es) Procedimientos para preparar acidos d,l-2hidroxi-4-alquiltiobutiricos
ATE440816T1 (de) Neues verfahren zur synthese substituierter alpha-aminoindanderivate
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
FR2871341B1 (fr) Procede de production de jeunes plants et/ou de micro pieds meres de plantes ornementales herbacees.
EP2597461A3 (fr) Procédé de mesure directe de multiples biodégradabilités
IL153561A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acid esters and method for the production thereof
MA33596B1 (fr) Procédé photochimique pour la production d'artémisinine
MA28704B1 (fr) Procede de production d'acide phosphorique
DE602005021461D1 (de) Verfahren zur herstellung von cabergolin
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
EA200801400A1 (ru) Новые производные индолизина, способ их получения и терапевтические композиции на их основе
ATE489355T1 (de) Mandelsäurederivate und deren herstellung
DE602005013007D1 (de) Verfahren zur herstellung von lactonen